HNL Lab Medicine Enhances Flu A Testing for H5N1 Avian Influenza

ALLENTOWN, Pa., Feb. 20, 2025 /PRNewswire/ — In response to updated CDC recommendations, HNL Lab Medicine will begin subtyping all positive influenza A samples from hospitalized patients to detect H5N1 Highly Pathogenic Avian Influenza. This enhanced surveillance aims to monitor…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.